Company news
Thalia Therapeutics PLC news in 2026
Thalia Therapeutics PLC's news releases, calls and decks from 2026, newest first.
Interim Results
September 30, 2026
New Patent Granted for miRisten in China
September 29, 2026
RNA gene-silencing cardiovascular program advances
September 25, 2026
Business Update and Notice of Results
September 15, 2026
Grant of Director Share Options
July 23, 2026
Result of AGM and Completion of Acquisition
July 17, 2026
Acquisition and £2.75 million Fundraise
June 24, 2026
New article: RNA medicine enters its second act
June 9, 2026
CEO Interview
June 2, 2026
CEO Interview: Thalia’s RNA Therapeutics Strategy
May 13, 2026
Change of Registered Address
April 20, 2026
Result of General Meeting and Change of Name
March 17, 2026
Notice of GM and Proposed Change of Name
February 27, 2026
CEO Appointment & Name Change Thalia Therapeutics
February 24, 2026